Christopher M. Armstrong

6.1k total citations · 1 hit paper
9 papers, 3.2k citations indexed

About

Christopher M. Armstrong is a scholar working on Molecular Biology, Public Health, Environmental and Occupational Health and Infectious Diseases. According to data from OpenAlex, Christopher M. Armstrong has authored 9 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 3 papers in Public Health, Environmental and Occupational Health and 2 papers in Infectious Diseases. Recurrent topics in Christopher M. Armstrong's work include Pharmacological Effects of Natural Compounds (2 papers), Sirtuins and Resveratrol in Medicine (2 papers) and Genetics, Aging, and Longevity in Model Organisms (2 papers). Christopher M. Armstrong is often cited by papers focused on Pharmacological Effects of Natural Compounds (2 papers), Sirtuins and Resveratrol in Medicine (2 papers) and Genetics, Aging, and Longevity in Model Organisms (2 papers). Christopher M. Armstrong collaborates with scholars based in United States and United Kingdom. Christopher M. Armstrong's co-authors include Leonard Guarente, Matt Kaeberlein, Shin‐ichiro Imai, Daniel E. Goldberg, Audrey R. Odom John, Caren L. Freel Meyers, David J. Meyers, Neil G. Berry, Paul M. O’Neill and Katherine Mann and has published in prestigious journals such as Nature, Nature Methods and Scientific Reports.

In The Last Decade

Christopher M. Armstrong

9 papers receiving 3.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase

2000 2.8k citations Shin‐ichiro Imai, Christopher M. Armstrong et al. Nature profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Christopher M. Armstrong United States	8	1.6k	1.6k	817	742	362	9	3.2k
Ivana Celic United States	13	1.5k 0.9×	1.3k 0.8×	545 0.7×	587 0.8×	414 1.1×	16	2.6k
Daniel X. Tishkoff United States	15	2.2k 1.4×	730 0.5×	419 0.5×	471 0.6×	302 0.8×	16	3.2k
Brett Marshall United States	10	1.2k 0.7×	1.1k 0.7×	391 0.5×	625 0.8×	410 1.1×	11	2.2k
Rosalba Perrone Italy	21	1.6k 1.0×	257 0.2×	193 0.2×	266 0.4×	193 0.5×	26	2.4k
Tassula Proikas‐Cezanne Germany	28	1.8k 1.1×	135 0.1×	578 0.7×	2.5k 3.4×	133 0.4×	55	4.0k
Ivana Novak Croatia	19	2.6k 1.6×	187 0.1×	464 0.6×	2.6k 3.5×	121 0.3×	28	4.3k
Mhairi C. Towler United Kingdom	17	2.0k 1.2×	167 0.1×	574 0.7×	401 0.5×	158 0.4×	19	2.8k
Kenji Takehana Japan	17	2.1k 1.3×	113 0.1×	547 0.7×	1.6k 2.2×	166 0.5×	26	3.6k
Marc Niere Norway	20	987 0.6×	649 0.4×	159 0.2×	206 0.3×	621 1.7×	30	2.0k
Paweł Bieganowski Poland	21	1.2k 0.8×	430 0.3×	145 0.2×	172 0.2×	381 1.1×	37	1.9k

Countries citing papers authored by Christopher M. Armstrong

Since Specialization

Citations

This map shows the geographic impact of Christopher M. Armstrong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher M. Armstrong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher M. Armstrong more than expected).

Fields of papers citing papers by Christopher M. Armstrong

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher M. Armstrong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher M. Armstrong. The network helps show where Christopher M. Armstrong may publish in the future.

Co-authorship network of co-authors of Christopher M. Armstrong

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher M. Armstrong. A scholar is included among the top collaborators of Christopher M. Armstrong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher M. Armstrong. Christopher M. Armstrong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Armstrong, Christopher M., et al.. (2022). Rapastinel accelerates loss of withdrawal signs after repeated morphine and blunts relapse to conditioned place preference. Pharmacology Biochemistry and Behavior. 221. 173485–173485. 3 indexed citations

Armstrong, Christopher M., Chandrakala Pidathala, Joo‐Young Park, et al.. (2016). Molecular Mechanism of Action of Antimalarial Benzoisothiazolones: Species-Selective Inhibitors of the Plasmodium spp. MEP Pathway enzyme, IspD. Scientific Reports. 6(1). 36777–36777. 18 indexed citations

Armstrong, Christopher M., Mary Clare Masters, Ting Li, et al.. (2015). Plasmodium IspD (2-C-Methyl-d-erythritol 4-Phosphate Cytidyltransferase), an Essential and Druggable Antimalarial Target. ACS Infectious Diseases. 1(4). 157–167. 45 indexed citations

Armstrong, Christopher M., et al.. (2015). Resistance to the Antimicrobial Agent Fosmidomycin and an FR900098 Prodrug through Mutations in the Deoxyxylulose Phosphate Reductoisomerase Gene ( dxr ). Antimicrobial Agents and Chemotherapy. 59(9). 5511–5519. 33 indexed citations

Kraft, Thomas E., Christopher M. Armstrong, Monique R. Heitmeier, Audrey R. Odom John, & Paul W. Hruz. (2015). The Glucose Transporter PfHT1 Is an Antimalarial Target of the HIV Protease Inhibitor Lopinavir. Antimicrobial Agents and Chemotherapy. 59(10). 6203–6209. 21 indexed citations

Bruin, Wändi Bruine de, et al.. (2009). Communicating About Xenotransplantation: Models and Scenarios. Risk Analysis. 29(8). 1105–1115. 9 indexed citations

Armstrong, Christopher M. & Daniel E. Goldberg. (2007). An FKBP destabilization domain modulates protein levels in Plasmodium falciparum. Nature Methods. 4(12). 1007–1009. 193 indexed citations

Armstrong, Christopher M., et al.. (2002). Mutations inSaccharomyces cerevisiaeGeneSIR2Can Have Differential Effects on In Vivo Silencing Phenotypes and In Vitro Histone Deacetylation Activity. Molecular Biology of the Cell. 13(4). 1427–1438. 44 indexed citations

Imai, Shin‐ichiro, Christopher M. Armstrong, Matt Kaeberlein, & Leonard Guarente. (2000). Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase. Nature. 403(6771). 795–800. 2810 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact